SS Innovations reports record Q2 revenue of $13.9M and 224 SSi Mantra systems installed

SS Innovations International/SSi Mantra

Revenue rose 39% to $13.9M in Q2 2026 as the company installed 30 SSi Mantra systems, bringing the total to 224 in 12 countries. It expects the FDA review to finish by the end of Q1 2027 and is targeting a CE mark by the end of 2026.

• First-half revenue $25.0M, up 66%; 56 systems installed in the half.
• 12,272 surgeries to date, including 175 telesurgeries and 637 cardiac cases.
• Gross margin 50.9%, down from 59.1% a year earlier.
• Cash $13.6M, no long-term debt; first-half net loss $6.2M.